LIVZON PHARMA (01513.HK) (000513.SZ) announced that as of the end of December last year, the company repurchased a total of 0.7238 million A-shares through centralized bidding, accounting for 0.08% of the company's total share capital, with a purchase price ranging from 37.5 to 38.37 yuan per share, with a total amount of funds used being 27.4946 million yuan.

As of the end of December last year, the company repurchased a total of 6.9737 million H-shares, accounting for 0.77% of the company's total share capital, with a purchase price ranging from 23.75 to 27.8 yuan per share, with a total amount of funds used being 0.183 billion yuan.